MedPath

Evaluation of the efficacy of Symbicort turbuhaler that target patients with bronchial ashtma complicated by COPD and bronchial asthma - Evaluation of diurnal variation in peak flow

Not Applicable
Recruiting
Conditions
bronchial asthma complicated by COPD and bronchial ashtma
Registration Number
JPRN-UMIN000007708
Lead Sponsor
Department of respirology, graduate School of Medicine, Chiba University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

>patient wiht an infection refractory to any antibiotics, or deep-seated mycoses >hitory of hypersensitivity to test drug

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diurnal variation in PEF by Piko-1
Secondary Outcome Measures
NameTimeMethod
expiratory NO eosinophil in sputum serum substance P FEV1.0 FEV1.0 in five minites after inhalaton of Symbicort or Procaterol Hydrochloride chest CT assessment of safty
© Copyright 2025. All Rights Reserved by MedPath